Skip to main content
Total Market Cap: $47,589,946,694 Volume (24h): $922,009,135

Zynerba Pharmaceuticals Inc.

Zynerba Pharmaceuticals Inc. (ZYNE) logo
Rank 75
About

Zynerba Pharmaceuticals is a biopharmaceutical company that develops transdermal cannabinoid therapies for the treatment of rare diseases. Conditions include Fragile X syndrome, types of epilepsy, and tourettes. Several products are in the preclinical stages of development. Founded in 2007, Zynerba Pharmaceuticals is based in Pennsylvania, US.

Website
$1.2600
USD
4.17%
Market cap
$29,229,492
Total volume
$550,723
Shares outstanding
23,198,010
Rank 75
Website
About

Zynerba Pharmaceuticals is a biopharmaceutical company that develops transdermal cannabinoid therapies for the treatment of rare diseases. Conditions include Fragile X syndrome, types of epilepsy, and tourettes. Several products are in the preclinical stages of development. Founded in 2007, Zynerba Pharmaceuticals is based in Pennsylvania, US.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
Nasdaq
ZYNE
$550,723
100%
$1.2600
Chart
Social media
Tweets by @ZynerbaPharma

Share widget

Copy widget code
Subscribe to our newsletter